PDF: Spero

Spero

Unique Antibiotic Pipeline To bat Spero Therapeutics

A Unique Antibiotic Pipeline for Today and Tomorrow. Spero Therapeutics’ experienced and dedicated employees are working tirelessly to advance our unique portfolio of novel drug candidates designed to combat Gram negative bacterial infections and rare disease through clinical development and regulatory approval.

Sphero STEM Kits & Robotics for Kids | Inspire STEM

As a leading STEM learning company with interactive robotics & STEM education kits, Sphero teaches kids to code at home & in classrooms. Order online now!

Spero QT®

GUARDIÕES XIV: DEUSA No século XXI, o deus Ajax retornou à Terra. Desta vez, em busca do devorador Triestelar, que ele havia aprisionado há quinhentos anos nos subsolo da América do Norte. Ele, igualmente, procura por Natascha, Nannie e Darius. Junto com ele, também veio sua irmã, a deusa Alana. Ambos os deuses, cada um a seu modo, causaram pânico na Terra. O mundo inteiro ficou ...

Spero Therapeutics: Remodeling Antibiotics

Spero thinks inhibiting this regulator, MvfR, could be a way of treating acute infections caused by P. aeruginosa. This organism is a frequent cause of pneumonia in ICU patients who need ventila tors to assist their breathing, and a constant problem for people with cystic fibrosis.

Spero Therapeutics Signs License Agreement with Everest

Spero is a multi asset, clinical stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for MDR bacterial infections. Spero’s lead product candidate, SPR994, is designed to be the first broad spectrum oral carbapenem class antibiotic for use in adults to treat MDR Gram negative infections.